11 research outputs found

    Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model

    Get PDF
    IntroductionTherapies for Leber hereditary optic neuropathy (LHON), in common with all disorders caused by mutated mitochondrial DNA, are inadequate. We have developed two gene therapy strategies for the disease: mitochondrial-targeted and allotopic expressed and compared them in a mouse model of LHON.MethodsA LHON mouse model was generated by intravitreal injection of a mitochondrialtargeted Adeno-associated virus (AAV) carrying mutant human NADH dehydrogenase 4 gene (hND4/m.11778G>A) to induce retinal ganglion cell (RGC) degeneration and axon loss, the hallmark of the human disease. We then attempted to rescue those mice using a second intravitreal injection of either mitochondrial-targeted or allotopic expressed wildtype human ND4. The rescue of RGCs and their axons were assessed using serial pattern electroretinogram (PERG) and transmission electron microscopy.ResultsCompared to non-rescued LHON controls where PERG amplitude was much reduced, both strategies significantly preserved PERG amplitude over 15 months. However, the rescue effect was more marked with mitochondrial-targeted therapy than with allotopic therapy (p = 0.0128). Post-mortem analysis showed that mitochondrial-targeted human ND4 better preserved small axons that are preferentially lost in human LHON.ConclusionsThese results in a pre-clinical mouse model of LHON suggest that mitochondrially-targeted AAV gene therapy, compared to allotopic AAV gene therapy, is more efficient in rescuing the LHON phenotype

    Molecular data suggests a Pliocene ‚Äď Early Pleistocene divergence date for the common and pygmy hippopotamus

    No full text
    Hippopotamid phylogeny has proven difficult to resolve with proposed relationships between extant and fossil species receiving mixed levels of support. Of particular interest is the divergence between the two extant hippopotamid species, the well-known common hippopotamus (Hippopotamus amphibius) and the enigmatic pygmy hippopotamus (Choeropsis liberiensis). Previous studies have relied on morphological and fossil evidence to identify the ancestral species at the core of this divergence and its timing. In this study, we assembled a molecular matrix of 26 nuclear gene sequences from 11 ungulate species with two primates as an outgroup. We used a Bayesian relaxed molecular clock approach to reconstruct a calibrated time tree for Cetartiodactyla and estimate the divergence date between the common and pygmy hippopotamus. While previous morphological studies have estimated this event to have occurred sometime during the Late Miocene (between 11.6 and 5.3 million years ago), our nuclear gene-based estimates suggest a more recent split of about 4.04 Ma (95% confidence interval: 8.31‚Äď1.97 Ma) via RelTime-ML or 2.4 Ma (95% confidence interval: 3.1‚Äď1.6 Ma) via MCMCTree. These more recent estimates correspond with the Early Pliocene ‚Äď Early Pleistocene sub-epochs and align most closely with the results of previous genomic studies. We discuss how our results compare with previous estimates based on both morphological and molecular studies, some of which extend the predicted range of this divergence date even further back in time. Our results suggest a different path of evolution for the understudied pygmy hippopotamus and reveal that morphological evidence alone may not resolve the correct hippopotamid phylogenetic and time trees. We suggest that the common and pygmy hippopotamus may be phylogenetically closer than once believed. Our results also call for further studies to develop a combined approach incorporating both molecular and morphological evidence to reach a consensus on the evolutionary patterns and timing that led to modern hippopotamid evolution

    Recent advances in pretreatment technologies for efficient hydrolysis of lignocellulosic biomass

    No full text

    Challenges and opportunities in improving the production of bio-ethanol

    No full text